Placebo Effect of Caffeine on Physiological Parameters and Physical Performance
David Ortiz-Sánchez1, Alfredo Bravo-Sánchez1,2, María Ramírez-delaCruz1
1Performance and Sport Rehabilitation Laboratory (DEPORSALUD), Faculty of Sports Sciences, University of Castilla-La Mancha, Avenida Carlos III s/n, 45071 Toledo, Spain.
Nutrients
|May 25, 2024
Summary
The placebo effect from high-dose caffeine did not significantly impact strength performance or perceived effort. However, it did lead to a lower resting heart rate and some reported side effects.
Area of Science:
- Sports Science
- Human Physiology
- Psychology
Background:
- The placebo effect is a well-documented phenomenon in various medical and performance contexts.
- Caffeine is a widely used ergogenic aid, but its effects can be influenced by psychological factors.
- Understanding the placebo effect in relation to caffeine and strength performance is crucial for athletes and researchers.
Purpose of the Study:
- To investigate the placebo effect of a high dose of caffeine (9 mg/kg) on physiological and performance measures.
- To analyze the impact of placebo on heart rate, heart rate variability, and strength tests.
- To evaluate perceived performance, effort, and side effects associated with the placebo condition.
Main Methods:
- 18 strength-trained participants underwent two trial days: one with caffeine-informed placebo ingestion and one control (no ingestion).
- Measurements included resting heart rate and heart rate variability (HRV) before strength assessments.
- Participants performed bench press and squat tests at varying intensities (50%, 75%, 90% of 1RM), followed by subjective evaluations.
Main Results:
- No significant differences were observed in most strength performance variables between placebo and control conditions.
- Resting heart rate decreased (p=0.040) and mean RR interval increased (p=0.032) in the placebo trial.
- Heart rate variability, perceived performance, and effort remained similar; however, side effects like nervousness were reported with the placebo.
Conclusions:
- The placebo effect, in this high-dose caffeine context, did not enhance strength performance, HRV, or perceived effort.
- A significant reduction in resting heart rate and an increase in mean RR interval were noted under placebo conditions.
- The study highlights that psychological factors can elicit physiological changes and subjective experiences, even without direct pharmacological effect on performance.
Related Concept Videos
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Experimental Designs
11.3K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.3K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Stimulants
187
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
187
Adrenergic Agonists: Mixed-Action Agents
701
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
701


